A drug initially developed to treat erectile dysfunction helps a subset of people with type 2 diabetes. Called yohimbine, the drug is effective in people with a variant of a gene called ADRA2A, researchers report October 8 in Science Translational Medicine.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.